Bibliografías temáticas / Arformoterol

Índice

  1. Artículos de revistas
  2. Capítulos de libros
  3. Actas de conferencias

Literatura académica sobre el tema "Arformoterol"

Autor: Grafiati
Publicado: 7 de junio de 2025
Última modificación: 2 de agosto de 2025

Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros

Elija tipo de fuente:

Consulte las listas temáticas de artículos, libros, tesis, actas de conferencias y otras fuentes académicas sobre el tema "Arformoterol".

Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.

También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.

Artículos de revistas sobre el tema "Arformoterol"

1

King, Paul T. "Pharmacotherapy of Chronic Obstructive Pulmonary Disease: Focus on Arformoterol Tartrate." Clinical Medicine. Therapeutics 1 (January 2009): CMT.S2584. http://dx.doi.org/10.4137/cmt.s2584.

Texto completo
Resumen
Arformoterol tartrate is a newly developed long-acting ssβ2-agonist with both acute and prolonged bronchodilator effects. It is formed of 2 isomers (R,R/R,R) which distinguishes it from the more commonly used racemic formoterol (R,R/S,S). The active isomer is the (R,R) and in vitro arformoterol may have more potent anti-inflammatory effects than formoterol. It can only be given by a nebulizer. There have been 5 randomized, blinded trials which have assessed the use of arformoterol in chronic obstructive pulmonary disease (COPD). Arformoterol has been demonstrated to improve lung function and s
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

&NA;. "Arformoterol." Drugs in R & D 5, no. 1 (2004): 25–27. http://dx.doi.org/10.2165/00126839-200405010-00004.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Hazra, Moumita. "A pharmacoepidemiological study of prescription patterns of β2 sympathomimetic bronchodilators in exacerbation of non-severe asthma in tertiary care hospitals, not needing hospitalization". International Journal of Basic & Clinical Pharmacology 8, № 12 (2019): 2674. http://dx.doi.org/10.18203/2319-2003.ijbcp20195276.

Texto completo
Resumen
Background: Arformoterol, the (R, R) enantiomer of the racemic (R, R / S, S) diastereomer, formoterol, is a short and long acting β2 agonist bronchodilator. Levosalbutamol, the (R, R) enantiomer of racemic diastereomer (R, R / S, S) salbutamol, has a greater affinity for the β2 receptor. Occupation of β2 receptors by agonists result in the activation of the Gs-adenylyl cyclase-cAMP-PKA pathway, followed by phosphorylative events leading to bronchial smooth muscle relaxation. The aim of this pharmacoepidemiological study was to analyse the prescription patterns, and prescription content analysi
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Cada, Dennis J., Terri Levien, and Danial E. Baker. "Arformoterol Tartrate." Hospital Pharmacy 42, no. 5 (2007): 447–54. http://dx.doi.org/10.1310/hpj4205-447.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Revill, P., N. Serradell, J. Bolós, and M. Bayés. "Arformoterol Tartrate." Drugs of the Future 31, no. 11 (2006): 944. http://dx.doi.org/10.1358/dof.2006.031.11.1047743.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
6

&NA;. "Arformoterol comparable to salmeterol for COPD." Inpharma Weekly &NA;, no. 1558 (2006): 6. http://dx.doi.org/10.2165/00128413-200615580-00013.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
7

Cazzola, Mario, Nicola A. Hanania, and Maria G. Matera. "Arformoterol tartrate in the treatment of COPD." Expert Review of Respiratory Medicine 4, no. 2 (2010): 155–62. http://dx.doi.org/10.1586/ers.10.16.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
8

Bhutnar, Arun, Anita Desai, Sachin Khapare, Sonali Vartak, Ajay Pangavhane, and Allwyn Andrandes. "Identification and Structural Characterization of Secondary Degradant of Arformoterol Impurity in LDPE Respules of Arformoterol Tartrate Inhalation Solution." American Journal of Analytical Chemistry 09, no. 05 (2018): 286–301. http://dx.doi.org/10.4236/ajac.2018.95022.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
9

King, Paul. "Role of arformoterol in the management of COPD." International Journal of Chronic Obstructive Pulmonary Disease Volume 3 (September 2008): 385–91. http://dx.doi.org/10.2147/copd.s753.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
10

Jeong, Jin-Hyuk, Jaewoon Son, Ji-Hyeon Kwon, Chang-Soo Han, and Chun-Woong Park. "Impact of Different Hydrate Forms of Magnesium Stearate as a Flow Control Agent on the Physical Stability and Inhalation Efficiency of Carrier-Based Formulations." Pharmaceutics 17, no. 6 (2025): 711. https://doi.org/10.3390/pharmaceutics17060711.

Texto completo
Resumen
Objectives: This study aimed to evaluate the impact of the different hydration states of magnesium stearate (Mg.st) anhydrate (AH), monohydrate (MH), and dihydrate (DH) on the aerodynamic performance and stability of carrier-based dry powder inhalation (DPI) formulations using arformoterol and budesonide as model drugs. Methods: DPI formulations were prepared using Inhalac 251 lactose and Mg.st in various hydrated forms. The physicochemical properties of Mg.st were characterized using powder X-ray diffraction, differential scanning calorimetry, Fourier-transform infrared spectroscopy, Karl Fis
Los estilos APA, Harvard, Vancouver, ISO, etc.
Más fuentes

Capítulos de libros sobre el tema "Arformoterol"

1

"ARFORMOTEROL." In Litt's Drug Eruptions & Reactions Manual. CRC Press, 2010. http://dx.doi.org/10.3109/9781841847665-19.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

"Arformoterol." In Hale’s Medications & Mothers’ Milk™ 2019. Springer Publishing Company, 2018. http://dx.doi.org/10.1891/9780826150356.0063.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.

Actas de conferencias sobre el tema "Arformoterol"

1

Panettieri, R., J. Walsh, M. Sims та ін. "Comparison of Efficacy and Safety of Arformoterol 15 μg Twice Daily with Arformoterol 30 μg Once Daily in Patients with COPD." У American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a4542.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
2

Karafilidis, John, Noelle Wilson, and Kenneth Sciarappa. "Evaluation Of Efficacy Following Arformoterol Tartrate 15 µg And Formoterol Fumarate 12 µg In Patients With Moderate To Severe COPD Stratified By Baseline Inspiratory Capacity." In American Thoracic Society 2012 International Conference, May 18-23, 2012 • San Francisco, California. American Thoracic Society, 2012. http://dx.doi.org/10.1164/ajrccm-conference.2012.185.1_meetingabstracts.a2934.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
3

Sciarappa, Kenneth, and John Karafilidis. "An Evaluation Of Response Rates Following Treatment With Nebulized Arformoterol 15 µg, Salmeterol MDI 42 µg Or Placebo Twice Daily In Patients With Moderate COPD." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1588.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
4

Karafilidis, John. "By Age Evaluation Of Efficacy And Safety Following Treatment With Nebulized Arformoterol 15 G, Salmeterol 42 G MDI And Placebo Twice Daily In Patients With Moderate COPD." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1587.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
5

Bauer, Andrea, Jay Holt, Eric Stewart, et al. "In Vitro Analysis Of The Effect Of Air Flow Rate On The Aerosol Properties Of Nebulized Arformoterol And Tiotropium And Fluticasone/Salmeterol Delivered Via Dry Powder Inhalers." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a1601.

Texto completo
Los estilos APA, Harvard, Vancouver, ISO, etc.
También puede estar interesado en las bibliografías ampliadas sobre el tema "Arformoterol" para tipos de fuentes particulares:
Artículos de revistas
Ofrecemos descuentos en todos los planes premium para autores cuyas obras están incluidas en selecciones literarias temáticas. ¡Contáctenos para obtener un código promocional único!

Pasar a la bibliografía